Stocks To Watch: Patanjali, SpiceJet, Titan, Kalyan, JSW Steel, Aurobindo, Hindalco, Brigade, Lupin

Oil Stocks: To be in focus after Brent crude futures hit $80.05 a barrel amid signs of tightening supplies and slower-than-expected U.S. inflation. 

Titan Company, Kalyan Jewellers India, Jewellery Stocks: Central government has restricted import of unstudded gold and certain gold articles. Importer would require a permission from the government for importing these gold products. Restrictions will not apply to imports under the India-UAE free trade agreement. 

JSW Steel: The company will replace HDFC on the S&P BSE Sensex from July 13. The announcement was made by the stock exchange on July 5. HDFC, which merged with HDFC Bank earlier this month, will delist from the benchmark index today.

Patanjali Foods: The company’s promoter will sell 7% stake over two trading days. Patanjali Ayurved will sell 2.53 crore shares or 7% stake in Patanjali Foods on July 13 and 14. The floor price of the offer shall be Rs 1000 apiece. The promoter will have an option to additionally sell up to 2% in the event of oversubscription. 

SpiceJet: Promoter to invest Rs 500 crore to strengthen airline's financial position. Ajay Singh, also the CMD of SpiceJet, will infuse capital through equity and or convertible securities on preferential basis. Funds to considered as equity share of promoter in government's ECLG scheme. 

Dr. Reddy’s Laboratories: The drugmaker’s biologics license application for its proposed biosimilar rituximab has been accepted by the U.S. Food and Drug Administration, European Medicines Agency and the U.K.’s Medicines and Healthcare Products Regulatory Agency. The biosimilar will be used in the treatment of rheumatoid arthritis, non-Hodgkin's lymphoma, chronic lymphocytic leukemia, pemphigus vulgaris, granulomatosis with polyangiitis and microscopic polyangiitis. 

Aurobindo Pharma: The company’s unit APL Healthcare has received final approval from the U.S. Food and Drug Administration to manufacture and sell Sevelamer Hydrochloride Tablets of doses 400 mg and 800 mg, equivalent to Renagel Tablets of Genzyme Corporation. The drug has an estimated market size of around $37 million for the twelve months ending May 2023, according to IQVIA. Sevelamer Hydrochloride Tablets is used to treat chronic kidney disease. 

Hindalco Industries: The company approved a proposal to sell its land at Kalwa in Maharashtra for Rs 595 crore and 1.5% of the sales revenue to Birla Estates, a unit of Century Textiles and Industries. 

Brigade Enterprises: The company named Pradyumna Krishna Kumar as Executive Director of the company for five years with effect from July 12. 

Lupin: U.S. FDA issued Form 483 with two observations after inspecting the company's Nagpur Oral Solid Dosage Facility from July 3 to July 11, 2023.

Texmaco Rail & Engineering: The company will meet on on July 17 to consider a proposal for raising funds by issuing equity shares or convertible securities either by preferential issue, rights issue, QIP or a combination of any of these.

Dreamfolk Services:  The company and Plaza Premium Group inked a contract to expand global lounge network and enhance travel experience for Indian passengers.

Subros: Company sees incremental business opportunities in vehicle AC component manufacturing with the amendment in Central Motor Vehicles Rules, 1989. Government announced that it will mandate AC in the cabins of N2 and N3 category vehicles, to be applicable from Jan. 1, 2025 onwards.

Sealmatic India: Becomes the first to receive accreditation with the ISO 19443 for nuclear applications in India and globally. ISO 19443 is a nuclear-specific quality management company standard designed to improve safety and quality throughout the nuclear supply chain.